Cumberland Pharmaceuticals Inc. CPIX
4.69 USD +0.25 (+5.63%)
Nov 5, 2026, 1:09 PM EST
4.32 Day range 4.69
1.85 52-week range 9.28
- YTD
- +17.83%
- 1 year
- +101.28%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 44.52M | 37.87M | 39.55M | 42.01M | 35.99M | |
| 37.85M | 31.28M | 33.49M | 32.89M | 27.17M | |
| -2.79M | -6.43M | -9.55M | -5.70M | -7.68M | |
| -2.84M | -6.48M | -6.28M | -5.57M | -3.51M | |
| -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 11.44M | 17.96M | 18.32M | 19.76M | 27.04M | |
| 76.82M | 75.58M | 81.78M | 92.93M | 84.46M | |
| 52.28M | 53.04M | 52.52M | 56.95M | 41.86M | |
| 10.18M | 20.57M | 18.43M | 20.96M | 16.06M | |
| 24.88M | 22.85M | 29.60M | 36.27M | 42.81M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 4.93M | -612.19K | 6.09M | 8.45M | 6.34M | |
| -4.71M | 57.84K | -105.69K | -13.67M | -501.89K | |
| -6.75M | 196.90K | -7.42M | -2.06M | -3.55M | |
| -2.66M | -179.71K | -453.05K | -2.07M | -354.46K | |
| -6.52M | -357.44K | -1.44M | -7.28M | 2.29M |